Andrea Todisco is a Gastroenterology physician affiliated with University of Michigan. OpenAlex indexes 117 publications with 2,231 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Medical Center Drive
3rd Floor Taubman Center Recp D
Ann Arbor, MI 481095362
Telephone
734-647-5944Registry record last updated 21 Mar 2012.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
73.5%H2 blocker41.2%Famotidine100%Part D≥35 patientsProton pump inhibitor27.2%Omeprazole85%Esomeprazole Magnesium15%Part D<11 patients+ 1 more class in this area
Blood & clotting
21.7%Solutions for parenteral nutrition21.7%Peg 3350-Electrolyte100%Part D≥49 patientsCancer & immunology
4.8%TNF inhibitor4.8%Humira(Cf) Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 1995–2023 per NIH RePORTER. The latest:
- Regulation of gastric metaplasia, dysplasia and neoplasia by Bone Morphogenetic Protein signaling
University of Michigan at Ann Arbor
FY2023$458,969R01DK121785 - Regulation of gastric metaplasia, dysplasia and neoplasia by Bone Morphogenetic Protein signaling
University of Michigan at Ann Arbor
FY2022$458,969R01DK121785 - Regulation of gastric metaplasia, dysplasia and neoplasia by Bone Morphogenetic Protein signaling
University of Michigan at Ann Arbor
FY2021$458,969R01DK121785
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Regulation of Gastric Lgr5+ve Cell Homeostasis by Bone Morphogenetic Protein (BMP) Signaling and Inflammatory Stimuli
Cellular and Molecular Gastroenterology and Hepatology
2018 - Regulation of Gastric Metaplasia, Dysplasia, and Neoplasia by Bone Morphogenetic Protein Signaling
Cellular and Molecular Gastroenterology and Hepatology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Matthias Kretzler, MD
University of Michigan
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”